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Minneapolis, MinnesotaABSTRACT This study presents a fluorescence-based assay that allows for direct measurement of protein binding to the
plasma membrane inside living cells. An axial scan through the cell generates a fluorescence intensity profile that is analyzed
to determine the membrane-bound and cytoplasmic concentrations of a peripheral membrane protein labeled by the enhanced
green fluorescent protein (EGFP). The membrane binding curve is constructed by mapping those concentrations for a popula-
tion of cells with a wide range of protein expression levels, and a fit of the binding curve determines the number of binding sites
and the dissociation coefficient. We experimentally verified the technique, using myosin-1C-EGFP as a model system and fit its
binding curve. Furthermore, we studied the protein-lipid interactions of the membrane binding domains from lactadherin and
phospholipase C-d1 to evaluate the feasibility of using competition binding experiments to identify specific lipid-protein interac-
tions in living cells. Finally, we applied the technique to determine the lipid specificity, the number of binding sites, and the disso-
ciation coefficient of membrane binding for the Gag matrix domain of human T-lymphotropic virus type 1, which provides insight
into early assembly steps of the retrovirus.INTRODUCTIONThe attachment of peripheral membrane proteins to lipid bi-
layers plays a critical role in many cellular functions, such
as lipid metabolism, cytoskeletal structure, vesicle traf-
ficking, signal transduction, cell differentiation, growth,
and apoptosis (1–3). Because membrane binding is crucial
for the cellular function of these proteins, characterization
of the membrane binding curve is a prerequisite for under-
standing the function and regulation of peripheral mem-
brane proteins. Most studies of protein-lipid interactions
are based on in vitro assays with membranes in the form
of lipid vesicles, supported lipid bilayers, or lipid mono-
layers (4–6). In some cases isolated membranes have been
used to go beyond simple lipid membranes (7,8). However,
these traditional assays study the protein and membrane ex
situ, and are unable to reproduce the native conditions that
give rise to the complex organization and dynamic behavior
of cellular membranes. Thus, a technique that directly
studies the membrane binding curve of proteins in living
cells is highly desirable, not only to validate previous ex
situ results, but also to explore the binding process in its nat-
ural environment.
This work describes a method for measuring the binding
of a fluorescently labeled protein with the plasma membrane
of a living cell. The technique utilizes an axial scan through
the cell to generate a z-scan fluorescence intensity profile.
The intensity profile is deconvolved into its cytoplasmic
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0006-3495/15/06/2648/10 $2.00counting for the local cell height and the point spread func-
tion (PSF) of the instrument. The membrane binding curve
is generated from the deconvolved cytoplasmic and mem-
brane intensity contributions for a population of cells
covering a sufficiently wide range of protein expression
levels. We further converted fluorescence intensities into
concentrations in the cytoplasm and at the membrane by
applying the brightness of the fluorescent-label enhanced
fluorescent green protein (EGFP). Information about the
binding affinity and the number of binding sites was recov-
ered from a fit of the experimental data with a Langmuir
isotherm. Moreover, competition binding experiments with
different peripheral membrane proteins provided informa-
tion about specific protein-lipid interactions at the plasma
membrane.
Our approach, which we call z-scan fluorescence profile
deconvolution (FPD), is related to z-scan fluorescence fluc-
tuation spectroscopy and earlier work by Benda et al. (9).
However, unlike z-scan fluorescence fluctuation spectros-
copy (10,11), which characterizes the axial dependence of
intensity fluctuations, z-scan FPD focuses specifically on in-
formation contained within the axial fluorescence intensity
profile to generate the experimental binding curve. We
applied z-scan FPD to investigate the interaction of
myosin-1C with the plasma membrane, generated the exper-
imental membrane binding curves, and determined its bind-
ing parameters. We also performed binding experiments
with a variety of peripheral membrane proteins with known
lipid targets to demonstrate the feasibility of competitive
binding assays in the cell. Finally we applied our technique
to study the membrane interactions of the matrix domain ofhttp://dx.doi.org/10.1016/j.bpj.2015.04.021
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viously observed that the Gag polyprotein and matrix (MA),
its membrane-binding domain, of HTLV-1 interact with the
plasma membrane at low cytoplasmic concentrations, which
is in stark contrast with the corresponding proteins of the hu-
man immunodeficiency virus type 1 (HIV-1) (11–13). Here
we expand our investigation of HTLV-1 virus assembly by
characterizing the membrane binding curve for the MA
domain of HTLV-1 Gag and the lipid-specificity of the
interaction.MATERIALS AND METHODS
Experimental setup
Experiments were carried out on a modified two-photon microscope, as
described previously in MacDonald et al. (10) and Chen et al. (14). Data
were taken with a 63 C-Apochromat water immersion objective (NA ¼
1.2) at an excitation wavelength of 1000 nm and an average power of
~0.3–0.4 mW after the objective (Carl Zeiss, Oberkochen, Germany).
Photon counts were detected by an avalanche photodiode (SPCM-AQ-
141; Perkin-Elmer, Dumberry, Quebec), recorded by a Flex02-01D card
(correlator.com, Bridgewater, NJ), and analyzed with programs written in
IDL 8.3 (Research Systems, Boulder, CO). For dual-channel measurements,
a dichroic mirror with a center wavelength of 580 nm split the fluorescence
emission into two detection channels. The green channel had an additional
84-nm-wide bandpass filter centered at 510 nm (Semrock, Rochester, NY)
to eliminate the reflected fluorescence of mCherry.
Z-scans were performed by using an arbitrary waveform generator
(Model No. 33250A; Agilent Technologies, Santa Clara, CA) to move
the PZ2000 piezo stage (ASI, Eugene, OR) along the z axis. The driving
signal from the arbitrary waveform generator was a linear ramp function
with a peak-to-peak amplitude of 2.4 V and a period of 10 s. The peak-
to-peak voltage corresponded to 24.1 mm of axial travel with the cells
occupying roughly 5 mm in the center of each pass. Data were acquired
at a frequency of 20 kHz for either a single z-scan or multiple z-scans.Sample preparation and plasmid construction
The pEGFP-C1 and pEGFP-N1 plasmids were purchased from Clontech
(Mountain View, CA) and the mCherry-C1 plasmid has been previously
described in Wu et al. (15). The EGFP-H-Ras plasmid was a gift from
Dr. Phillips (New York University School of Medicine, New York, NY).
The Myosin1C-EGFP (Myo1C-EGFP) plasmid and the EGFP-labeled PH
domain of Phospholipase C-delta (EGFP-PLCd-PH) plasmid were gifts
from Dr. Albanesi (University of Texas Southwestern Medical Center, Dal-
las, TX). The EGFP-labeled C2 domain of lactadherin (Lact-C2-EGFP)
plasmid was purchased from Addgene (Plasmid 22852; Cambridge, MA).
The Lact-C2-mCh plasmid was subcloned from the Lact-C2-EGFP plasmid
into a mCherry-c1 backbone. The miniGAP-EGFP plasmid (the first 10
amino acids of GAP43) was a gift from Dr. Digman (University of Califor-
nia-Irvine, Irvine, CA). The miniGAP-mCh plasmid was cloned from mini-
GAP-EGFP and amplified by PCR with a 50 primer that encodes an XhoI
restriction site and a 30 primer that encodes an EcoRI site. The HTLV-1
MA-EGFP plasmid has been previously described in Smith et al. (11).
All sequences were verified by automatic sequencing.
All cellular studies were performed using transiently transfected U2OS
cells that were obtained from ATCC (Manassas, VA) and maintained in
10% fetal bovine serum (Hyclone Laboratories, Logan, UT) and DMEM
medium. Cells were subcultured in eight-well cover-glass chamber slides
(Nalge Nunc International, Rochester, NY) 12 h before transfection. Tran-
sient transfections were carried out 24 h before measurement usingGeneJET (Thermo Scientific, Carlsbad, CA) according to the manufac-
turer’s instructions. Immediately before measurement, the growth medium
was replaced with Dulbecco’s PBS (phosphate-buffered saline) with cal-
cium and magnesium (BioWhittaker, Walkerville, MD). For binding
competition studies, cotransfections were performed with the two plasmid
types mixed together at a given mole ratio before adding GeneJET (Thermo
Fisher Scientific). Specifically, pLact-C2-EGFP: pLact-C2-mCh was mixed
at a 1:3 ratio, while for all other competition experiments plasmids were
mixed at a 1:6 (EGFP-labeled/mCh-labeled) ratio. During measurement,
the fluorescence intensity ratio of the green and red detection channel
was used to select cells expressing both proteins at a concentration ratio
that matched or exceeded the plasmid ratio (15,16). This selection ensured
that each measured cell contains a sufficient excess of the competitor over
the probed protein.Z-scan calibration of PSF
The PSF for our two-photon microscope is well approximated by the modi-
fied squared Gaussian-Lorentzian point-spread function (mGL-PSF),
PSFðr; zÞ ¼
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as originally described by MacDonald et al. (10). The radial and axial beam
waist are characterized by w0 and zR. The y parameter adjusts the axialdecay of the PSF while maintaining a Gaussian cross section. The PSF
parameters were determined by a z-scan calibration procedure as previously
reported (10), which provided values of zR ¼ 1.025 0.1 mm, y ¼ 2.205
0.3, and w0 ¼ 0.475 0.05 mm. The mGL-PSF volume is determined by
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and the cross-sectional area at the center of the PSF is given by
A ¼ ðpw2=4Þ (10).0 0The z-scan intensity profile
Modeling of the z-scan intensity profile is based on the radially integrated
PSF given by
RIPSFðzÞ ¼
Z N
0
PSFðr; zÞ2prdr:
It is convenient to use the radially integrated PSF to define a scaled volume
function~vVðz; zB; zTÞ ¼ 1
VN
Z zTz
zBz
RIPSFðzÞdz
and a scaled-area function~vAðz; zMÞ ¼ 1
A0
RIPSFðzM  zÞ
(10). The z-scan fluorescence intensity profile F(z) can be represented using
the scaled volume and scaled area functions. For a cytoplasmic protein with
the top and bottom membrane located at zB and zT, the intensity profile is
given by FðzÞ ¼ F0 ~vVðz; zB; zTÞ, while the intensity profile of a protein
bound to a membrane located at zM is given by FðzÞ ¼ F0 ~vAðz; zMÞ (10,11).
Calculating the RIPSF function for the mGL-PSF described by Eq. 1
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The scaled volume and area function were implemented in IDL 8.3
(Research Systems, Boulder, CO) for data analysis.Z-scan data analysis
The photon counts sampled at 20 kHz were rebinned by a factor of 80 by
software, which corresponds to a z-scan sampling time of Tz ¼ 4 ms. The
z-scan speed vz ¼ 4.82 mm/s resulted in a step size Dz ¼ vzTz ¼ 19.3 nm
between binned photon counts kz. Fluorescence intensity was determined
by F(z)¼ kz/Tz. The experimental z-scan intensity profile F(z) was analyzed
in IDL 8.3 by least-squares fitting to Eq. 4 with a Levenberg-Marquardt
algorithm, where the PSF parameters zR and y were fixed to the
calibrated values, and the standard deviation sbinned of the binned photon
counts was estimated from the SD sK of the unbinned counts by
sbinned ¼ sk
ﬃﬃﬃﬃﬃﬃ
NB
p
, with NB ¼ 80 representing the number of samples in a
single bin. In addition, brightness measurements inside the cytoplasm
have been carried out as previously described in MacDonald et al. (10)
and Smith et al. (11) in the thick section of 10–20 cells expressing EGFP.
The average brightness l from this calibration experiment was computed
(17,18) and served as the monomeric brightness value to convert intensities
into concentrations.FIGURE 1 Z-scan intensity profile (solid line) for Myo1C-EGFP in two
U2OS cells. The fit (shaded line) to Eq. 4 together with the membrane in-
tensity components (dashed lines) and cytoplasmic component (dotted-
dashed line). (A) Profile from a cell with a low cytoplasmic intensity and
fit (c2red ¼ 1.4, FCyto,N ¼ 14.8 kcps, FT ¼ 51.9 kcps, FB ¼ 56.9 kcps).
(B) Profile from a cell with a high cytoplasmic intensity and fit (c2red ¼
1.5, FCyto,N¼ 103 kcps, FT¼ 52.6 kcps, FB¼ 53.9 kcps). To see this figureRESULTS
Z-scan intensity profile of a peripheral membrane
protein
A scan of the excitation spot along the z axis of a cell records
the fluorescence intensity profile F(z) of the labeled protein.
The intensity profile of a protein found at the plasma mem-
brane and in the cytoplasm contains the signal contributions
from three distinct cellular layers. The first layer is given by
the bottom plasma membrane located at zB, followed by a
cytoplasmic layer and the top plasma membrane located at
zT. The fluorescence intensity profile of this geometry, which
we refer to as a delta-slab-delta profile, has been recently
described in Smith et al. (11) as
FdsdðzÞ ¼ FB ~vAðz; zBÞ þ FCyto;N~vVðz; zB; zTÞ þ FT ~vAðz; zTÞ;
(4)
with FB and FT being the maximum fluorescence intensity at
in color, go online.the membrane layers and FCyto,N representing the limitingBiophysical Journal 108(11) 2648–2657intensity of a thick cytoplasmic layer. The scaled volume
~vV and area ~vA function are defined by Eqs. 2 and 3.
We measured z-scan intensity profiles from U2OS cells
expressing Myo1C-EGFP. The panels of Fig. 1 display in-
tensity profiles taken from two cells that differ in their pro-
tein expression level. Each experimental intensity profile
(solid line) was fit to Eq. 4 to isolate the fluorescence con-
tributions from each membrane (dotted line) and from the
cytoplasm (dotted-dashed line), which are represented by
the three terms of Eq. 4. The sum of these three terms deter-
mines the fitted z-scan intensity profile (shaded line). The
relative contributions to the intensity profile from mem-
brane-bound and cytosolic protein differ significantly for
the two cells. Deconvolving the intensity profile into its
components allowed us to quantify these differences. We
will follow this approach in the rest of the article to generate
a membrane binding curve, by analyzing intensity profiles
from a cell population made up of cells that individually
display different levels of protein expression.
We expect the fluorescence intensity values to stay con-
stant if the binding process of the peripheral membrane pro-
tein is at equilibrium. As a control, we performed repeated
z-scans on cells expressing H-Ras-EGFP over extended
time periods. Each z-scan is fit by Eq. 4 to identify the
cell height and the fluorescence intensities in each of the
In Situ Protein-Membrane Binding 2651three layers, as illustrated in Fig. 2. The top (Fig. 2 A,
dashed) and bottom (solid) membrane intensity, as well as
the cytosolic intensity (Fig. 2 B, dotted-dashed), remained
remarkably stable even when the cell height (Fig. 2 C, solid)
changed during the experiment. The fluorescence intensities
at the top and bottom membrane were matched, which sug-
gests that the affinity of binding to either membrane was the
same. The concentration cCyto of cytoplasmic H-Ras-EGFP
is determined from the cytosolic fluorescence intensity by
FCyto,N¼ cCytolVN, where VN is the PSF volume and l rep-
resents the brightness of the EGFP protein that was
measured by an independent control experiment. The pro-
tein concentration sM at the membrane is determined from
the intensity FM at the membrane by a similar relation,
FM ¼ sMlA0, where VN is replaced by the PSF area A0.
Applying these relations to the data of Fig. 2 yielded surface
concentrations of sB ¼ 900 mm2 and sT ¼ 920 mm2 for
the bottom and top membranes and a cytoplasmic concen-
tration cCyto ¼ 71 mm3.Membrane binding curve
Cells transiently transfected with EGFP-labeled Myo1C
were selected and their z-scan intensity profile measured.
The membrane and cytoplasmic intensity were determined
by a fit of the intensity profile and are plotted in Fig. 3 A.
The uncertainty in the fitted membrane and cytoplasmicFIGURE 2 Fit parameters of consecutive z-scan intensity profiles taken
in an U2OS cell expressing EGFP-H-Ras. (A) Fluorescence intensities at
the top (dashed line) and bottom (solid line) membrane remain stable
(FB ¼ 93.75 3.2 kcps, FT ¼ 95.65 4.3 kcps). (B) Cytoplasmic intensity
(dot-dashed line) is constant (FCyto,N ¼ 10.0 5 0.8 kcps). (C) The cell
thickness (solid line) changed within the first few minutes and then re-
mained approximately constant. To see this figure in color, go online.intensities was on the order of, or smaller than, the symbol
size, and was not plotted. The same condition applied
to all membrane binding plots shown in this work. The
membrane fluorescence intensity versus cytoplasmic fluo-
rescence intensity displays a concentration-dependent
response, which saturates at high cytoplasmic intensities.
Fluorescence intensities from the bottom membrane (open
triangles) and the top membrane (solid triangles) are
in close agreement. The data represent the binding curve
FM(FCyto,N) of the peripheral membrane protein to the
plasma membrane. To model the experimental data,
consider a cytoplasmic protein P that binds a free membrane
binding site M with dissociation coefficient K to become a
membrane-associated protein MP, M þ P%K MP. The frac-
tional saturation q of the membrane binding sites is
described by the Langmuir isotherm,
q ¼ sM
s0
¼ cCyto
K þ cCyto; (5)
where cCyto and sM are the cytoplasmic and membrane-
bound protein concentrations, while s0 represents the con-
centration of the total number of membrane binding sites
M0 ¼ M þ MP.
We relate the Langmuir-isotherm to fluorescence inten-
sities to facilitate the analysis of the data in Fig. 3 A. TheFIGURE 3 Fluorescence membrane binding curve of Myo1C-EGFP in
U2OS cells. (A) Fluorescence intensity at the bottom (open triangles) and
top (solid triangles) membrane versus fluorescence intensity in the cyto-
plasm. The fit (dotted line) to Eq. 6 recovers F0 ¼ 83 kcps and FK ¼ 24
kcps. (Top and right axes) Cytoplasmic and membrane-bound protein con-
centrations. (B) Membrane intensity fraction versus fluorescence intensity
in the cytoplasm (open triangles) is well approximated by Eq. 8 (dotted
line) with the same F0 and FK as determined in the top panel. To see this
figure in color, go online.
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are connected to the fluorescence intensities as described
earlier, FCyto,N ¼ cCytolVN and FM ¼ sMlA0. We further
introduce the saturating fluorescence intensity at the mem-
brane, F0 ¼ s0lA0, and FK ¼ KlVN, to relate both the
maximum binding site concentration and the dissociation
coefficient to an intensity. Inserting these relations into
Eq. 5 provides an alternate formulation of the Langmuir
isotherm in terms of fluorescence intensities,
FM ¼ qF0 ¼ F0FCyto;N
FK þ FCyto;N: (6)
A fit of the intensity data in Fig. 3 A to Eq. 6 with F0 and FK
as free parameters is shown as a solid line with FK¼ 245 5
kcps and F0¼ 835 10 kcps. We use the EGFP brightness l,
the PSF volume VN, and the area A0 to convert these values
into the dissociation coefficient K ¼ 160 5 30 mm3 ¼
270 5 50 nM and saturation concentration s0 ¼ 750 5
90 mm2.
An alternate way to represent membrane binding is to
graph the membrane intensity fraction
fM ¼ FM
FM þ FCyto;N (7)
versus the cytoplasmic intensity FCyto,N. Because the z-scan
intensity profile distinguishes between the bottom and top
membrane, we further introduce the intensity fraction fB
of the bottom membrane and the intensity fraction fT of
the top membrane, which are defined by replacing FM
with FB and FT in Eq. 7, respectively. The membrane inten-
sity fraction of the Myo1C data as a function of cytoplasmic
intensity is shown in Fig. 3 B. The dashed line in Fig. 3 rep-
resents the Langmuir isotherm model,
fM ¼ F0
FK þ FCyto;N þ F0; (8)
with values for F0 and FK as determined above. The mem-
brane intensity fraction decays monotonically with cyto-
plasmic concentration, because an increase in protein
concentration leads to a further depletion of the available
membrane binding sites. Evaluating Eq. 8 for a cytoplasmic
concentration FCyto,N ¼ 0 determines the maximum
limiting value
f M ¼
F0
FK þ F0
for the membrane intensity fraction, which for the Myo1CFIGURE 4 Fluorescence membrane binding curve (open triangles) for
LactC2-EGFP in U2OS cells with fit (solid line) to Eq. 6 (F0 ¼
530 kcps, FK ¼ 68 kcps). Competitive binding curve for LactC2-EGFP
coexpressed with LactC2-mCh at a ratio of 1:3 (open squares) agrees
with predicted binding curve (dashed line). To see this figure in color, go
online.data is 0.78. Thus, the saturation concentration s0 and the
dissociation coefficient K are not independent variables,
but linked by f M. If the data of the fluorescence membrane
binding curve FM(FCyto,N) are insufficient to identify s0
and K unambiguously, an extrapolation of the measured
fractional membrane intensity fM can be used to identifyBiophysical Journal 108(11) 2648–2657the ratio of both parameters, which for intensity-based nota-
tion is given by FK=F0 ¼ ð1 f MÞ=f M.Lipid binding protein domains
Lactadherin is a peripheral membrane protein shown to
interact with PS (phosphatidylserine) lipids through its C2
domain (19,20). We measured U2OS cells transiently trans-
fected with an EGFP-labeled Lact-C2 fragment (Lact-C2-
EGFP) and determined the experimental membrane-binding
curve (see Fig. 4,open triangles).Afit (solid line) to theLang-
muir-isotherm bindingmodel leads to a saturation concentra-
tion s0 ¼ 41005 1100 mm2 and a dissociation coefficient
K ¼ 7005 310 nM. In a followup experiment, we cotrans-
fected Lact-C2-EGFP and Lact-C2-mCh using a plasmid
ratio of 1:3. We selected cells that express both proteins and
measured the membrane-binding curve (open squares) of
Lact-C2-EGFP from the fluorescence intensity traces in the
green detection channel. The membrane saturation intensity
F0 is much lower than in the previous experiment, reflecting
the presence of Lact-C2-mCh that competes with the green-
labeled protein. We divided the amplitude of the Lact-C2-
EGFP Langmuir-isotherm curve (solid line) by 4 to account
for the binding site competition provided by Lact-C2-mCh.
The binding curve (dashed line) with the rescaled amplitude
is in good agreement with the experimental data, and illus-
trates the feasibility of binding competition assays.
We also examined the plasma-membrane binding curve
of the PH domain of phospholipase C-delta 1 (PLCd-PH),
which is known to interact with PI(4,5)P2 (phosphatidylino-
sitol 4,5-bisphosphate) lipids (21). The experimental
membrane-binding data (Fig. 5 A, open circles) of EGFP-
labeled PLCd-PH were determined in U2OS cells and fit
to a Langmuir isotherm model (solid line) with s0 ¼
6200 5 1300 mm2 and K ¼ 5.3 5 1.4 mM. Next, we
FIGURE 5 Fluorescence membrane binding curves in U2OS cells.
(A) Binding curve for EGFP-PLC-PH (open circles) and fit (solid line) by
Eq. 6 (F0 ¼ 909 kcps, FK ¼ 620 kcps). Competitive binding curve for
EGFP-PLC-PH coexpressed with MiniGAP-mCh (solid stars) and fit
(dotted line) by Eq. 6 (F0 ¼ 76 kcps, FK ¼ 71 kcps). (B) Binding curve
for EGFP-PLC-PH (open circles) and fit (solid line) as shown in (A).
Competitive binding curve for EGFP-PLC-PH coexpressed with LactC2-
mCh (asterisks) closely tracks the binding curve for EGPF-PLC-PH alone.
To see this figure in color, go online.
FIGURE 6 (A) Fluorescence membrane binding curve (triangles) for
HTLV-1 MA-EGFP expressed in U2OS cells. (Shaded symbols) Same
data are shown in (B) and (C). The fit (solid line) to Eq. 6 leads to F0 ¼
288 kcps and FK ¼ 18 kcps. (B) Competitive binding curve (solid squares)
of MA-EGFP coexpressed with miniGAP-mCh. (C) Competitive binding
curve (solid diamonds) of MA-EGFP coexpressed with LactC2-mCh and
fit (dashed line) to Eq. 6 (F0 ¼ 68 kcps, FK ¼ 8 kcps). To see this figure
in color, go online.
In Situ Protein-Membrane Binding 2653coexpressed EGFP-PLCd-PH with miniGAP-mCh. We
selected cells that express both proteins and determined
the membrane-binding curve (Fig. 5 A, solid stars) of the
EGFP-PLCd-PH from the intensity signal of green detection
channel. The presence of miniGAP led to a drastic change in
the binding curve for PLCd-PH, which was also reflected by
the fit of the binding data to a Langmuir isotherm model
(dashed line). Plotting the same data with a reduced scale
allowed the behavior at low intensities to be more clearly
visualized (see Fig. S1 in the Supporting Material). The
marked decrease in the amplitude of the binding curve
implied that miniGAP and PLCd-PH compete for the
same binding sites at the membrane. This observation is
consistent with the fact that both proteins are known to
interact with PI(4,5)P2 (22,23).
For a control experiment, we coexpressed EGFP-PLCd-
PH and Lact-C2-mCh in U2OS cells. The data in Fig. 5 B
revealed that the experimental membrane-binding data of
EGFP-PLCd-PH in the presence (asterisks) or absence
(open circles) of Lact-C2, closely track one another.
In vitro studies have reported that PLCd-PH interacts with
PI(4,5)P2, while Lact-C2 interacts with PS (19,20). Thus,
both proteins are expected to target different binding sites
at the membrane, which is corroborated by our experimental
binding data.HTLV-1 matrix
We recently investigated the MA domain of Gag in an effort
to uncover the initial assembly steps of the retrovirus
HTLV-1 Gag (11–13). MA was chosen as a simplified test
system for initial studies of the assembly process, because
it is the primary driver of Gag association with the inner
leaflet of the plasma membrane, but lacks the ability to asso-
ciate into large multimers (24,25). Previous work has shown
that HTLV-1 MAGag forms homo-complexes at the plasma
membrane, but is monomeric in the cytoplasm (11–13,26).
Because the membrane binding mechanism of HTLV-1
MA is not well understood, we decided to investigate the
lipid specificity, binding affinity, and saturation concentra-
tion of the process. We transiently transfected U2OS cells
with EGFP-labeled MA and determined the cytoplasmic
and membrane-bound fluorescence intensities from multiple
cells. The data (Fig. 6 A, open triangles) show a concentra-
tion-dependent increase in the fluorescence signal at the
membrane. A fit (solid line) of the data to a Langmuir-
isotherm resulted in a dissociation coefficient of K ¼
230 5 130 nM and a membrane saturation concentration
of s0 ¼ 2800 5 700 mm2.
Further, we performed competition studies to probe the
lipid specificity of HTLV-1 MA binding to the plasma
membrane. We first coexpressed HTLV-1 MA-EGFP withBiophysical Journal 108(11) 2648–2657
2654 Smith et al.miniGAP-mCh to probe binding to PI(4,5)P2. In Fig. 6 B,
the binding curve (solid squares) of HTLV-1 MA-EGFP in
the presence of miniGAP-mCh overlaps with the binding
data (open triangles) taken for HTLV-1 MA-EGFP alone.
This observation suggests that PI(4,5)P2 is not the main lipid
target of HTLV-1 MA. We next coexpressed HTLV-1 MA-
EGFP with Lact-C2-mCh to probe PS binding. The presence
of Lact-C2-mCh led to a strong change in the binding curve
of HTLV-1 MA-EGFP (Fig. 6 C, solid diamonds) as
compared to HTLV-1 MA-EGFP alone (open triangles).
This result indicates that PS lipids are an important binding
target of HTLV-1 MA. The dashed line represents the fit
curve to a Langmuir-isotherm with a dissociation coefficient
of K¼ 1305 16 nM and a membrane saturation concentra-
tion of s0 ¼ 840 5 110 mm2.DISCUSSION
Our data demonstrate that it is feasible to measure the mem-
brane binding curve of fluorescently-labeled proteins inside
living cells with z-scan FPD analysis. The technique relies
on the deconvolution of the intensity profile with the help
of an accurately parameterized PSF. We have found that
the modified Gaussian-Lorentzian model provides a very
faithful representation of the PSF for the two-photon instru-
ments in our lab (10,11). An additional consideration is the
cell height at the scan position, which must be sufficiently
large to distinguish membrane and cytoplasmic contribu-
tions by the deconvolution process. In our experience, the
cell thickness should be at least twice the axial beam waist
zR of the PSF, which implies a minimum thickness of ~2 mm
for our setup, a condition that was satisfied for all cell mea-
surements presented in this study. Thus, while our study
focused on U2OS cells, z-scan FPD has the potential to be
expanded to other cell types as long as their minimum
height is ~2 mm.
Analysis of z-dependent intensity distributions of fluores-
cently labeled cells is not a novel concept in itself. For
example, z-stack image analysis has been widely used in
the fluorescence field to determine protein localization,
which includes work from Aisiku et al. (27) and Dowal
et al. (28), where they segment the z-dependent intensity
distribution of Gaq and Phospholipase Cb into membrane
and cytoplasmic regions. However, segmentation does not
result in a quantitative separation of fluorescence signals
from different compartments, because the PSF blurs the
signal contributions. Modeling approaches have been used
to account for the effect of the PSF, including recent work
that used a three-dimensional Gaussian PSF to identify the
membrane-bound and free intensities of tBid in an in vitro
environment (29). However, an accurate and quantitative
analysis requires a parameterized PSF to avoid systemic
biases. Z-scan FPD achieves this goal and partitions the in-
tensity profile into its membrane and cytoplasmic compo-
nents. While this study was performed on a two-photonBiophysical Journal 108(11) 2648–2657microscope, we expect that the same types of experiments
are feasible on a one-photon confocal instrument. Extension
of the z-scan method only requires a proper parameteriza-
tion of the one-photon observation volume O (30), which re-
places the PSF of two-photon excitation.
In this work we focused on the binding of a number of
different protein domains to PI(4,5)P2 and PS lipids. It has
been estimated that the surface density of PI(4,5)P2 lipid
on the cell membrane is between 3000 and 5000 mole-
cules/mm2 (31) and that PLCd-PH binds to PI(4,5)P2 with
a dissociation coefficient ranging from 2 to 3 mM in vitro
(21,32). Fitting the binding curve of EGFP-PLCd-PH (see
Fig. 5 B) determined a surface concentration of 6200 5
1300 molecules/mm2 and a binding dissociation coefficient
of K ¼ 5.35 1.4 mM in situ, which are close to the previ-
ously reported in vitro values. We also applied our tech-
nique to study the binding of Lact-C2-EGFP to PS lipids.
Estimates of the lipid composition at the plasma membrane
indicate that PS is more abundant than PI(4,5)P2 (31). Thus,
we expected to measure a higher surface density than for
EGFP-PLCd-PH, but experimentally observed a surface
density of 4100 molecules/mm2 for Lact-C2-EGFP (see
Fig. 5 A), which is less than what we measured for EGFP-
PLCd-PH. However, the z-scan binding assay does not mea-
sure the lipid concentration, but the protein concentration at
the membrane. Thus, accessibility to the targeted lipid as
well as competition for binding sites from other cellular
proteins will modulate the saturation concentration at the
membrane. The binding affinity of LactC2 for PS on lipid
vesicles has been measured by FRET experiments with
reported in vitro dissociation coefficients of K ¼ 290–
350 nM (33,34), which agrees within a factor of 2 with
our result.
Myo1C, a member of the myosin I superfamily, is known
to associate with plasma membrane lipids (PI(4,5)P2 and PS)
through electrostatic interactions involving the tail domain
(35,36). Hokanson and Ostap (37) and Hokanson et al. (38)
studied the binding of the Myo1C tail fragment to large uni-
laminar vesicles containing 2% PI(4,5)P2, and reported KD
values that depended on labeling and ranged from 230 to
530 nM. We determined a K ¼ 270 nM for full-length
Myo1C-EGFP in U2OS cells, which is in close agreement
with the in vitro results from the Myo1C fragments. Finding
the same affinity for the fragment and the full-length protein
suggests that the tail domain of Myo1C is the main determi-
nant for themembrane binding energy. This property has also
been found in other proteins. For example, PLCd and its PH
domain bind with a very similar affinity (39).
We used the matrix domain of HTLV-1 Gag to probe the
early assembly steps of this retrovirus. The MA domain of
Gag contain a myristoyl moiety and a highly basic region,
which are each important for membrane binding (reviewed
in Hamard-Peron and Muriaux (40)). For HIV-1 the
MA domain and full length Gag only associate with the
plasma membrane at high protein concentrations, where
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sequestered myristoyl moiety (13,40). In contrast, the MA
domain and full-length Gag of HTLV-1 have been found
to associate with the plasma membrane even at the lowest
measurable fluorescence intensities (13). While this obser-
vation seems to imply a very high binding affinity, the
data in Fig. 6 indicate a dissociation constant of several hun-
dred nanomolar, which is a lower affinity than originally ex-
pected. This apparent inconsistency can be resolved by
considering the limiting value f M of the membrane fraction
as the cytoplasmic protein concentration approaches zero,
which depends on the surface concentration of binding sites
and the affinity. The fit parameters of the binding curve for
MA result in f M ¼ 0:92, which reflects the large ratio of F0
to FK. In other words, a sufficient high number of binding
sites compensates for a lower binding affinity and results
in a significant population of membrane-bound proteins
even at the lowest expression levels. In the case of MA,
>90% of the protein is at the plasma membrane at very
low cytoplasmic protein concentrations.
The membrane binding partner of HTLV-1 Gag is still an
open question. It has been shown that HIV-1 Gag binding
with PI(4,5)P2 is essential for function (25). However,
when Inlora et al. (41) studied the interaction between
PI(4,5)P2 and the MA domain of HTLV-1, they concluded
that PI(4,5)P2 was not essential for particle assembly. This
finding is corroborated by our in situ competitive binding
assay (see Fig. 6 B), which demonstrates that PI(4,5)P2 is
not an essential binding partner of MA. Instead, we found
that HTLV-1 MA-EGFP binds to PS lipid at the plasma
membrane (Fig. 6 C). This observation agrees with
in vitro work reporting that HTLV-1 Gag binds to lipo-
somes containing PS (41).
The same study argued that HTLV-1 MA interacts with
lipids primarily through electrostatic and not lipid-specific
interactions. If electrostatic interactions are the main driver
for membrane association, we would expect to observe
competition for the PI(4,5)P2 binding site, because the net
charge of PI(4,5)P2 at neutral pH is expected to be 3 or
4 (39), while for PS it is 1. However, the data in Fig. 6
B show no or at best only weak interaction between
HTLV-1MA and PI(4,5)P2, because the competitive binding
curve (solid squares) is only slightly lower than the binding
curve for MA alone (open triangles). A potential explana-
tion for the stronger interaction with PS lipids might be
found in the distribution of basic residues in the matrix pro-
tein. Unlike HIV-1 MA, the basic residues of HTLV-1 MA
are distributed throughout the sequence (42). The higher
abundance of PS over PI(4,5)P2 at the inner leaflet of the
plasma membrane might lead to a larger number of local in-
teractions with the distributed basic residues of the protein,
which would result in an increased binding energy. Thus,
our data suggest that interaction with PS lipids at the mem-
brane plays an important role in the early assembly step of
the HTLV-1 virus.We briefly note that it is important to choose a suitable
scan location within the cell. If the protein of interest is
excluded from certain cellular compartments, then the pres-
ence of such a compartment along the scan trajectory will
lead to a dip in the intensity profile, provided the compart-
ment is comparable in size to the PSF. We use a bright-field
image of the cell to find a position that avoids large struc-
tures such as the nucleus and the surrounding endomem-
brane system. We further perform at least two successive
z-scans at each scan location, because movement of vesicles
or other compartments between two successive scans intro-
duces changes in the intensity profile. We only accept data
where the intensity profile remains unchanged between
scans. While these methods have proven sufficient for
studying protein binding to the plasma membrane, a more
sophisticated approach will be needed for proteins that
interact with internal membranes to account for their com-
plex spatial distribution inside the cell.
FPD analysis of the z-scan intensity profile separates
membrane-bound and cytoplasmic protein components in
terms of intensity. To translate these intensities into absolute
concentrations requires an additional conversion factor from
an independent experiment. In this work, we used the
brightness of monomeric EGFP (determine from an inde-
pendent control experiment) as our conversion factor to
identify concentrations. However, even in the absence of a
conversion factor, it is still possible to quantitatively
compare intensity-based binding curves because the con-
centration and intensity are linearly related. This point is
illustrated by the competition experiments depicted in
Figs. 4–6.
The heterogeneity of the cytoplasm introduces uncer-
tainty in brightness experiments and therefore in the deter-
mination of protein concentration, an issue that has been
studied early on (43). We have found that the uncertainty
of brightness measurements in cells is ~10% (10), which
implies an ~10% uncertainty in determining the con-
centration. Similarly, we also observed a brightness uncer-
tainty of ~10% at the plasma membrane (11). This study
generated membrane binding curves through single-point
z-scan measurements taken over a sample of cells. How-
ever, the scatter in the data points of the measured binding
curves appears much larger than the measurement uncer-
tainty. This spread of intensities at the membrane for a
given cytoplasmic concentration might reflect cell-to-cell
variations or be caused by spatial heterogeneity at the
cell membrane. To address this issue, we plan to expand
the z-scan technique by combining it with x-y scans to
explore small regions of the plasma membrane. This
approach should allow us to investigate the origin of the
scatter in the binding curve and potentially expand the
reach of the technique to study binding of proteins with a
nonuniform spatial distribution at the plasma membrane.
While these developments will strengthen the technique,
the results obtained from simple z-scans are alreadyBiophysical Journal 108(11) 2648–2657
2656 Smith et al.impressive. Single-point z-scans have proven to be suffi-
cient for quantitative analysis of the binding and competi-
tion experiments shown here.
In summary, z-scan FPD offers a method for character-
izing binding curves of peripheral membrane proteins
within their native environment. The technique not only of-
fers a way to test the binding results from ex situ studies
within a cellular system, but also promises to reveal novel
features. For example, competition assays can be per-
formed to identify specific lipid-protein binding partners.
We anticipate that the ability to quantitatively monitor
membrane binding in situ should prove useful for func-
tional studies of membrane-binding proteins.SUPPORTING MATERIAL
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